This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg, Germany

Christian Wetter, Ph.D.
Portfolio Leader, Pharma Technical Regulatory at Roche
Speaker

Profile

Christian is a chemist by training. He completed his studies at ETH Zurich and his PhD at University of Marburg.

He started his career in industry in chemical development at Roche in 2004. In 2009 he moved to Regulatory CMC at Novartis where he worked in roles with increasing responsibilities. In 2020 Christian moved back to Roche and currently acts as a Portfolio Leader in technical regulatory.

In his current role Christian’s focus lies on oligonucleotide development, new technologies development, device development, as well as nitrosamines/mutagenic impurities. In the oligonucleotide field he leads the regulatory subteam in the European Pharma Oligoncleotide Consortium (EPOC).

Agenda Sessions

  • Chairman's Remarks

    13:55